{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:49:40Z","timestamp":1794638980513,"version":"4.9.1"},"reference-count":23,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,8,15]],"date-time":"2002-08-15T00:00:00Z","timestamp":1029369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> Recent studies have shown that CD38 expressed as a percentage of the antigen positivity can predict prognosis and disease progression in patients with B\u2010cell chronic lymphocytic leukaemia (B\u2010CLL). The present study showed that quantification of CD38 expressed as antibody\u2010binding capacity (ABC) improves the prognostic value of the percentage of CD38 positivity in B\u2010CLL. In a cohort of 81 patients with B\u2010CLL, a level of CD38 expression of \u2265\u200a30% and an ABC value of 250 proved statistically valid cut\u2010off points to predict disease progression (% CD38: <jats:italic>P<\/jats:italic>=0\u00b70027; ABC: <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b70001). There was a positive and significant correlation between the percentage of CD38 expression and ABC (<jats:italic>r<\/jats:italic>=0\u00b77; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b70001). There was a better discrimination of survival using ABC rather than percentage CD38 positivity (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b70001 compared with <jats:italic>P<\/jats:italic>=0\u00b70027). Only ABC predicted for survival in patients under 60\u2003years of age (<jats:italic>P<\/jats:italic>=0\u00b70076) or with stage A disease (<jats:italic>P<\/jats:italic>=0\u00b70195). Both percentage CD38 and ABC discriminated between time to first treatment for all patients but only ABC predicted time to treatment for stage A patients (<jats:italic>P<\/jats:italic>=0\u00b70004). In conclusion, CD38 positivity is an important prognostic factor in B\u2010CLL. However, quantification of CD38 is superior to the percentage positivity and should be used clinically in conjunction with other variables of predictive value to identify B\u2010CLL patients that are likely to progress.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03673.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:47:01Z","timestamp":1047365221000},"page":"755-761","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Quantification improves the prognostic value of CD38 expression in B\u2010cell chronic lymphocytic leukaemia"],"prefix":"10.1111","volume":"118","author":[{"given":"Tryfonia","family":"Mainou\u2010Fowler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Dignum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope R. A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W. G.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey P.","family":"Summerfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,8,15]]},"reference":[{"key":"e_1_2_15_2_1","first-page":"371a","article-title":"CD38 expression definesclinical and biological characteristics in B\u2010CLL","volume":"96","author":"Benet I.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1840"},{"key":"e_1_2_15_4_1","first-page":"366a","article-title":"CD38 expression identifies two distinct prognostic subsets in B\u2010chronic lymphocytic leukaemia (B\u2010CLL)","volume":"96","author":"Del Poeta G.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_15_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.9.2633"},{"key":"e_1_2_15_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304083281404"},{"key":"e_1_2_15_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1848"},{"key":"e_1_2_15_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.7.2455"},{"key":"e_1_2_15_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.181"},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197801)41:1<23::AID-CNCR2820410106>3.0.CO;2-Y"},{"key":"e_1_2_15_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(99)00147-2"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.3.1101"},{"key":"e_1_2_15_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90148-1"},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.6.1902"},{"key":"e_1_2_15_15_1","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1096\/fasebj.10.12.8903511","article-title":"Human CD38, a cell\u2010surface protein with multiple functions","volume":"10","author":"Metha K.","year":"1996","journal-title":"FASEB Journal"},{"key":"e_1_2_15_16_1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V85.2.307.307","article-title":"Advances in the biology and treatment of B\u2010cell chronic lymphocytic leukaemia","volume":"85","author":"O'Brien S.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_15_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050149"},{"key":"e_1_2_15_18_1","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1182\/blood.V76.7.1375.1375","article-title":"Multiple myeloma: increased circulating lymphocytes carrying plasma cell\u2010associated antigens as an indicator of poor prognosis","volume":"76","author":"Omede P.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_15_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.3.1588"},{"key":"e_1_2_15_20_1","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.4049\/jimmunol.151.6.3119","article-title":"A B\u2010lymphocyte surface molecule medicating activation and protection from apoptosis via calcium channels","volume":"151","author":"Santos\u2010Argumedo L.","year":"1993","journal-title":"Journal of Immunology"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.6.1892"},{"key":"e_1_2_15_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240532"},{"key":"e_1_2_15_23_1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.V88.4.1365.bloodjournal8841365","article-title":"CD38 Expression distinguishes two groups of B\u2010cell chronic lymphocytic leukaemias with different responses to anti\u2010IgM antibodies and propensity to apoptosis","volume":"88","author":"Zupo S.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_15_24_1","first-page":"42","article-title":"Chronic lymphocytic leukaemia: staging and prognostic factors","volume":"25","author":"Zwiebel J.A.","year":"1998","journal-title":"Seminars in Oncology"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03673.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03673.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03673.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:50:31Z","timestamp":1697442631000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03673.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,15]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03673.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03673.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8,15]]},"assertion":[{"value":"2002-08-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}